Diabetes and metabolism Archives - Page 5 of 7

Diabetes and metabolism

Clinical Articles

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Expert/s: Lindsey Schier, Dr Scott Kanoski

Diabetes and metabolism

Podcasts

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Expert/s: Dr Michael Hii

Diabetes and metabolism

Clinical Articles

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Expert/s: Dr Sarah Wood

Diabetes and metabolism

Clinical Articles

Obesity & metabolic syndrome in kids is a growing problem

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

Expert/s: Lynnette Hoffman

Diabetes and metabolism, Endocrinology, Ophthalmology

Videos

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

Expert/s: Prof Richard O'Brien

Diabetes and metabolism

Clinical Articles

Routine screenings could prevent vision loss for diabetes patients

1 in 3 people with diabetes develop retinopathy, but up to half aren’t getting screened

Expert/s: Ben Falkenmire

Diabetes and metabolism

Clinical Articles

Low carb diets for T2D remission?

Diabetes remission is still a new concept for many—but Dr Peter Brukner wants to change that.

Expert/s: Healthed

Diabetes and metabolism

Podcasts

Low carbohydrate diets to manage T2D

How Type 2 Diabetes (T2D) remission sounds impossible, but is achievable and endorsed by Diabetes Australia in their "Type 2 Diabetes Position Statement" October 2021, and The compelling and beneficial impact of introducing a low carb dietary intervention to patients with T2D, rather than surgery or prescribing more drugs.

Expert/s: Dr Peter Brukner OAM

Diabetes and metabolism, Surgery

Podcasts

Bariatric surgery update – Which option for which patient?

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Expert/s: Prof John Dixon

Diabetes and metabolism

Clinical Articles

10 part type-2 diabetes podcast series

Expert/s: Healthed

Diabetes and metabolism

Clinical Articles

Is treating obesity the future of managing type 2 diabetes?

Type 2 diabetes is a silent pandemic, affecting one in 20 people in Australia and an estimated 500 million people around the world.

Expert/s: Dr Priya Sumithran

Diabetes and metabolism

Podcasts

T2D devices – What GPs need to know about CGM

Patients on medications that have a low incidence of hypoglycaemia with T2DM do not need finger-prick blood glucose testing. GPs will rely on HbA1C to guide management. However, its use in Sick Days management is still important

Expert/s: A/Prof Gary Kilov AM

Diabetes and metabolism

WHO’s recommendation against the use of artificial sweeteners for weight loss leaves many questions unanswered

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Bariatric surgery options for obesity

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

GLP-1s for T2D – the earlier the better?

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

Obesity & metabolic syndrome in kids is a growing problem

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

Routine screenings could prevent vision loss for diabetes patients

1 in 3 people with diabetes develop retinopathy, but up to half aren’t getting screened

Low carb diets for T2D remission?

Diabetes remission is still a new concept for many—but Dr Peter Brukner wants to change that.

Low carbohydrate diets to manage T2D

Bariatric surgery update – Which option for which patient?

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

10 part type-2 diabetes podcast series

Is treating obesity the future of managing type 2 diabetes?

Type 2 diabetes is a silent pandemic, affecting one in 20 people in Australia and an estimated 500 million people around the world.

T2D devices – What GPs need to know about CGM

Patients on medications that have a low incidence of hypoglycaemia with T2DM do not need finger-prick blood glucose testing. GPs will rely on HbA1C to guide management. However, its use in Sick Days management is still important

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.

Diabetes and metabolism

Do low-calorie sweeteners help with weight management? And are they safe for long-term use?

Obesity is the disease of our generation- managing obesity and the complications of obesity to suit each individual patient's requirements and needs.

Experts say GLP-1 RAs should be prescribed more often and earlier, citing compelling benefits for type 2 diabetes—but the PBAC has other ideas.

It’s no anomaly for Associate Professor Gary Leong to see patients as young as 10 who weigh 100 kilograms.

In this Product Explainer, Endocrinologist Prof Richard O'Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

1 in 3 people with diabetes develop retinopathy, but up to half aren’t getting screened

Diabetes remission is still a new concept for many—but Dr Peter Brukner wants to change that.

Most commonly used bariatric-metabolic surgical procedures, their mechanism of action, patient selection, weight loss and health outcomes.

Type 2 diabetes is a silent pandemic, affecting one in 20 people in Australia and an estimated 500 million people around the world.

Patients on medications that have a low incidence of hypoglycaemia with T2DM do not need finger-prick blood glucose testing. GPs will rely on HbA1C to guide management. However, its use in Sick Days management is still important

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.